Ionis Pharmaceuticals (IONS)
(Delayed Data from NSDQ)
$47.68 USD
-2.22 (-4.45%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $47.69 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Earnings News For IONS
-
Ionis (IONS) Q2 Earnings and Revenues Beat, Stock Rises
-
Ionis Pharmaceuticals: Q2 Earnings Snapshot
-
Ionis Pharmaceuticals (IONS) Reports Q2 Loss, Tops Revenue Estimates
-
Ionis reports second quarter 2024 financial results
-
Ionis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: Should You Buy?
-
Ionis Pharmaceuticals (IONS) Down 0.7% Since Last Earnings Report: Can It Rebound?
-
Ionis (IONS) Q1 Loss Narrower Than Expected, Sales Miss
-
Ionis Pharmaceuticals (IONS) Reports Q1 Loss, Misses Revenue Estimates
-
Ionis Pharmaceuticals: Q1 Earnings Snapshot
-
Ionis reports first quarter 2024 financial results
-
Ionis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
-
Ionis Pharmaceuticals (IONS) Down 2.8% Since Last Earnings Report: Can It Rebound?
-
Ionis (IONS) Q4 Loss Narrower Than Expected, Sales Surge Y/Y
-
Ionis Pharmaceuticals: Q4 Earnings Snapshot
-
Ionis Pharmaceuticals (IONS) Reports Q4 Loss, Tops Revenue Estimates
-
Ionis reports fourth quarter and full year 2023 financial results
-
Ionis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
-
Ionis (IONS) Q3 Loss Wider Than Expected, Sales Beat Estimates
-
Ionis Pharmaceuticals: Q3 Earnings Snapshot
-
Ionis reports third quarter 2023 financial results
-
Ionis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
Why Is Ionis Pharmaceuticals (IONS) Up 1.4% Since Last Earnings Report?
-
Ionis (IONS) Q2 Loss Narrows Y/Y, Sales Surpass Estimates
-
Ionis Pharmaceuticals (IONS) Q2 Earnings and Revenues Surpass Estimates (Revised)
-
Ionis Pharmaceuticals (IONS) Q2 Earnings and Revenues Surpass Estimates